drugset / Trial / NCT03639168
Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)
NaSingle-groupOpen-labelTreatment
Summary
The investigators conducted this study to evaluate the efficacy of Chidamide combined with cisplatin in recurrent or metastatic head and neck adenoid cystic carcinoma.
Timeline
- Start
- 2018-06-06
- Primary completion
- 2020-06-24
- Completion
- 2021-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | Intravenous |
| Subject | Tucidinostat | Small molecule | 20 mg | Oral |